$Veradigm (MDRX.US)$reports earnings for the last 3 months and a full year on February 25th. after recently pulling back I feel like this talk is at a good price point to make an entry and also try to front run the earnings call strategy groups who usually only seem to look a week ahead. this was a position I wanted to enter before I noticed this scenario so it works out well. having any kind of telemedicine in your portfolio right now is a good thing I think...
Veradigm股票讨论
2022前3季度营收增长6.2%,营业利润萎缩40%,净利润受停止经营利润影响重新进入亏损区间。
财报延误通常不是好现象,加上近期财务数据的大起大落,暂时缺乏投资价值。
暂无评论